The current UCSD CFAR is a component of the AID Research Institute, an Organized Research Unit in the University of California System. We propose to expand the CFAR into a regional, comprehensive AIDS Research Center, with participating members drawn from UCSD and neighboring institutions including the Salk Institute, Scripps Research Foundation, the Burnham Cancer Research Foundation, and the La Jolla Institute for Allergy and Immunology. Dr. Flossie Wong-Staal and Dr. Douglas Richman will continue to serve as the Director and Co-director of the new Center. Their cooperation and complementary areas of expertise should strengthen the interaction of basic and clinical AIDS research as well as ensuring a continuation in leadership. The central mission of the new CFAR is to develop improved vaccines and therapies for HIV infection and associated disease through: (i) Basic Research in the areas of molecular pathogenesis and immunopathogenesis of HIV infection; (ii) Utilization of insights from basic research to develop pre-clinical and clinical trials of therapies and vaccines; (iii) Further clinical research to address fundamental scientific and practical medical issues; (iv) Providing leadership and serving as a regional resource to coordinate, stimulate and cross- fertilize all of the above to foster synergism, economies of scale and novel and creative approaches. The new CFAR will have a greatly strengthened Administrative Core to effectively coordinate the diverse activities of the Center. The Developmental Core will also be expanded in accordance with the growth in participating membership from neighboring institutions. A number of new cores will be established to keep pace with current needs and research activities on HIV. The proposed cores include five basic sciences cores: Molecular Biology, Virology, Flow Cytometry, Gene Therapy and Signal Transduction/Apoptosis and four clinical cores: Clinical Data and Outcomes, Clinical Investigation, Behavioral and Health Function and Primary Isolation and Specimen Banking. In addition, we will have access to a number of core facilities at different sites that are not directly funded by CFAR. A set of policies and procedures has been established to evaluate the performance of each core and to guide decisions in funding reallocation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
2P30AI036214-06
Application #
2627906
Study Section
Special Emphasis Panel (ZAI1-SCO-A (J1))
Project Start
1994-04-01
Project End
2001-02-28
Budget Start
1998-09-01
Budget End
1999-02-28
Support Year
6
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Chaillon, Antoine; Gianella, Sara; Lada, Steven M et al. (2018) Size, Composition, and Evolution of HIV DNA Populations during Early Antiretroviral Therapy and Intensification with Maraviroc. J Virol 92:
Bengtson, Angela M; Pence, Brian W; Eaton, Ellen F et al. (2018) Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015. Antivir Ther 23:363-372
Dubé, Karine; Gianella, Sara; Concha-Garcia, Susan et al. (2018) Ethical considerations for HIV cure-related research at the end of life. BMC Med Ethics 19:83
Mittal, María Luisa; Bazzi, Angela Robertson; Rangel, María Gudelia et al. (2018) 'He's not my pimp': toward an understanding of intimate male partner involvement in female sex work at the Mexico-US border. Cult Health Sex 20:961-975
Letendre, Scott; Bharti, Ajay; Perez-Valero, Ignacio et al. (2018) Higher Anti-Cytomegalovirus Immunoglobulin G Concentrations Are Associated With Worse Neurocognitive Performance During Suppressive Antiretroviral Therapy. Clin Infect Dis 67:770-777
Basova, Liana; Najera, Julia A; Bortell, Nikki et al. (2018) Dopamine and its receptors play a role in the modulation of CCR5 expression in innate immune cells following exposure to Methamphetamine: Implications to HIV infection. PLoS One 13:e0199861
Eren, Kemal; Murrell, Ben (2018) RIFRAF: a frame-resolving consensus algorithm. Bioinformatics 34:3817-3824
de Almeida, Sérgio Monteiro; Ribeiro, Clea E; Rotta, Indianara et al. (2018) Biomarkers of neuronal injury and amyloid metabolism in the cerebrospinal fluid of patients infected with HIV-1 subtypes B and C. J Neurovirol 24:28-40
Martin, Thomas C S; Rauch, Andri; Salazar-Vizcaya, Luisa et al. (2018) Understanding and Addressing Hepatitis C Virus Reinfection Among Men Who Have Sex with Men. Infect Dis Clin North Am 32:395-405
Jenks, Jeffrey D; Hoenigl, Martin (2018) Treatment of Aspergillosis. J Fungi (Basel) 4:

Showing the most recent 10 out of 921 publications